Thomas K. Equels

2015

In 2015, Thomas K. Equels earned a total compensation of $1.1M as CEO & President at Hemispherx Biopharma, a 33% decrease compared to previous year.

Compensation breakdown

Bonus$262,092
Option Awards$45,518
Salary$719,273
Other$94,971
Total$1,121,854

Equels received $719.3K in salary, accounting for 64% of the total pay in 2015.

Equels also received $262.1K in bonus, $45.5K in option awards and $95K in other compensation.

Rankings

In 2015, Thomas K. Equels' compensation ranked 7,389th out of 13,638 executives tracked by ExecPay. In other words, Equels earned more than 45.8% of executives.

ClassificationRankingPercentile
All
7,389
out of 13,638
46th
Division
Manufacturing
2,783
out of 5,187
46th
Major group
Chemicals And Allied Products
1,009
out of 1,857
46th
Industry group
Drugs
813
out of 1,531
47th
Industry
Biological Products, Except Diagnostic Substances
141
out of 260
46th
Source: SEC filing on July 18, 2017.

Equels' colleagues

We found four more compensation records of executives who worked with Thomas K. Equels at Hemispherx Biopharma in 2015.

2015

William Carter

Hemispherx Biopharma

Chief Executive Officer

2015

David Strayer

Hemispherx Biopharma

Chief Scientific Officer

2015

Adam Pascale

Hemispherx Biopharma

Chief Financial Officer

2015

Peter Rodino

Hemispherx Biopharma

General Counsel

News

You may also like